Literature DB >> 35382392

The effects of a single carbon dioxide and hot water hand bath on acral perfusion in systemic sclerosis: A randomized, clinical study.

Uwe Lange1, Stephanie Bogensperger1, Ingo H Tarner1, Ulf Müller-Ladner1.   

Abstract

Secondary Raynaud's phenomenon is the most common manifestation of systemic sclerosis, affecting more than 99% of systemic sclerosis patients, and a major cause of morbidity. Frequent and prolonged secondary Raynaud's phenomenon attacks not only cause severe discomfort and pain but also ischemic acral tissue damage. In addition to vasoactive drugs, carbon dioxide (CO2) hand bath and hot water bath are potential non-pharmacological treatment options which can be self-administered by affected patients at any time. In order to compare the efficacy of these two physical measures, this randomized, clinical study evaluated the effects of a single CO2 hand bath in patients with systemic sclerosis and secondary Raynaud's phenomenon and a healthy control group versus a single hot water hand bath on acral perfusion in systemic sclerosis by Doppler ultrasonography. None of the patients had currently digital ulcers, a vasoactive medication or a concomitant vascular disease. CO2 immersion induced an acute hemodynamic response, whereas hot water immersion had no significant effect on acral perfusion in systemic sclerosis.
© The Author(s) 2019.

Entities:  

Keywords:  Doppler ultrasonography; Systemic sclerosis; carbon dioxide; hot water

Year:  2019        PMID: 35382392      PMCID: PMC8922646          DOI: 10.1177/2397198318819919

Source DB:  PubMed          Journal:  J Scleroderma Relat Disord        ISSN: 2397-1983


  9 in total

1.  Colour Doppler ultrasound of the nailbed: an objective tool for monitoring responses to vasodilatory treatment of connective tissue disorders?

Authors:  M Keberle; H P Tony; M Hau; C Kessler; R Jahns; M Jenett
Journal:  Rheumatology (Oxford)       Date:  2001-08       Impact factor: 7.580

2.  Doppler ultrasound identifies increased resistive indices in SSc.

Authors:  N Bregenzer; O Distler; R Meyringer; J Schölmerich; U Müller-Ladner; G Lock
Journal:  Ann Rheum Dis       Date:  2004-01       Impact factor: 19.103

3.  Microcirculatory and clinical effects of serial percutaneous application of carbon dioxide in primary and secondary Raynaud's phenomenon.

Authors:  J Schmidt; P Monnet; B Normand; R Fabry
Journal:  Vasa       Date:  2005-05       Impact factor: 1.961

4.  Two- and three-dimensional Doppler sonographic evaluation of the effect of local cryotherapy on synovial perfusion in wrist arthritis.

Authors:  J Strunk; K Strube; P Klingenberger; U Müller-Ladner; U Lange
Journal:  Rheumatology (Oxford)       Date:  2006-03-14       Impact factor: 7.580

Review 5.  Mechanisms of vascular damage in systemic sclerosis.

Authors:  Ulf Müller-Ladner; Oliver Distler; Lidia Ibba-Manneschi; Elena Neumann; Steffen Gay
Journal:  Autoimmunity       Date:  2009-11       Impact factor: 2.815

6.  Acute haemodynamic response to carbon dioxide hand immersion in patients with systemic sclerosis evaluated by Doppler ultrasonography.

Authors:  Matthias Müller-Eschner; Katinka Albrecht; Ingo H Tarner; Ulf Müller-Ladner; Johannes Strunk; Uwe Lange
Journal:  Clin Exp Rheumatol       Date:  2012-11-29       Impact factor: 4.473

7.  Effects of serial percutaneous application of carbon dioxide in intermittent claudication: results of a controlled trial.

Authors:  B R Hartmann; E Bassenge; M Hartmann
Journal:  Angiology       Date:  1997-11       Impact factor: 3.619

8.  Assessment of microvascular changes in Raynaud's phenomenon and connective tissue disease using colour doppler ultrasound.

Authors:  M Keberle; H P Tony; R Jahns; M Hau; R Haerten; M Jenett
Journal:  Rheumatology (Oxford)       Date:  2000-11       Impact factor: 7.580

Review 9.  [Therapeutic management of acral manifestations of systemic sclerosis].

Authors:  Martin F Meyer; Adrien Daigeler; Marcus Lehnhardt; Hans-Ulrich Steinau; Harald H Klein
Journal:  Med Klin (Munich)       Date:  2007-03-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.